BENU
0436.826.929 · rovalta.com · 27/09/2026
BENU
Financial year 2026 · Closed on 31/01/2026
Overview
Identity
Source · BCE/KBOBENU is a Public limited company incorporated in 1989. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Wavre. It employs on average 370,2 ETP workers (FTE).
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0436.826.929
- Incorporation
- 08/02/1989
- Legal form
- Public limited company
- Registered office
- Avenue Pasteur 2
1300 Wavre · WallonieSee on map - Contributed capital
- 94 295 888,00 €
- Latest accounts
- 31/01/2026
- Average workforce
- 370,2 ETP
Joint committees (1)
- 313
Financials
Source · NBB, 31 filingsTrend over 11 financial years
| 2026 | 2025 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 172,2 M € | +3.5% | 166,4 M € | +19.2% | 139,6 M € | -4.5% | 146,3 M € | +4.6% | 139,8 M € |
| EBITDA | 3,6 M € | +11.7% | 3,2 M € | -51.6% | 6,6 M € | -11.7% | 7,5 M € | +1.3% | 7,4 M € |
| Operating result | 1,1 M € | -14.7% | 1,3 M € | -35.3% | 1,9 M € | -17.5% | 2,4 M € | +209% | 762,3 k € |
| Net result | 1,4 M € | -13.0% | 1,7 M € | +7.3% | 1,6 M € | +25.9% | 1,2 M € | -77.0% | 5,4 M € |
| Balance sheet | |||||||||
| Equity | 43,1 M € | +12.4% | 38,3 M € | +64.0% | 23,4 M € | +7.1% | 21,8 M € | +6.0% | 20,6 M € |
| Total assets | 84,1 M € | +36.1% | 61,8 M € | +4.3% | 59,3 M € | +8.7% | 54,5 M € | +4.6% | 52,2 M € |
| Cash | 992,6 k € | +45.6% | 681,5 k € | -20.2% | 854,2 k € | -4.1% | 890,7 k € | -28.6% | 1,2 M € |
| Debts | 40,5 M € | +73.8% | 23,3 M € | -34.6% | 35,7 M € | +10.0% | 32,4 M € | +3.2% | 31,4 M € |
| Other | |||||||||
| Workforce | 370,2 ETP | -2.6% | 380,2 ETP | -11.1% | 427,8 ETP | -1.7% | 435,3 ETP | -2.2% | 445,3 ETP |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/01/20263 active · 20 ended
Active mandates
Ended mandates
Other companies at this address
Avenue Pasteur 2 1300 Wavre| Company | CBE no. |
|---|---|
2B CLINIC● Active | 0881.533.723 |
BENU Management● Active | 0474.171.632 |
BENU PMCB● Active | 0474.171.830 |
CENTRE RX DE WAVRE● Active | 0450.606.867 |
Créons Ensemble 1● Bankrupt | 0731.719.104 |
Créons Ensemble 2● Bankrupt | 0731.719.203 |
Créons Ensemble 3● Bankrupt | 0731.719.302 |
| 0556.980.037 | |
ESPLANADE DE LA PAIX ONE● Bankrupt | 0635.932.691 |
ESPLANADE DE LA PAIX TWO● Bankrupt | 0635.932.889 |
| 0846.594.818 | |
IMMO X● Active | 0450.607.065 |
LLOYDS GROUP● Active | 0892.331.902 |
M.D.D. PHARMA● Active | 0437.759.119 |
PAREXEL BELGIUM● Active | 0475.837.161 |
PHOENIX Belgium● Active | 0653.962.122 |
SOFIADIS● Active | 0811.294.835 |
URG ANYTIME● Active | 1015.405.601 |
VAQUAFERRA● Bankrupt | 0421.054.432 |
VAQUALAN Real Estate● Bankrupt | 0674.844.539 |
Financials
Full financial information
Source · NBB| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Type of account | Full model | Full model | Full model | Full model | Full model | Full model |
| Start of the financial year | 01/02/2025 | 01/02/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 |
| Closing of the financial year | 31/01/2026 | 31/01/2025 | 31/01/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 |
| Length of the financial year | 12 months | 12 months | 10 months | 12 months | 12 months | 12 months |
| Filing date | 25/06/2026 | 10/07/2025 | 09/07/2024 | 03/10/2023 | 30/09/2022 | 17/09/2021 |
| General meeting | 17/06/2026 | 18/06/2025 | 19/06/2024 | 11/09/2023 | 12/09/2022 | 13/09/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 31 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Full model | 31/01/2026 | 17/06/2026 | 25/06/2026 | French | |
| Full model | 31/01/2025 | 18/06/2025 | 10/07/2025 | French | |
| Full model | 31/01/2024 | 19/06/2024 | 09/07/2024 | French | |
| Full model | 31/03/2023 | 11/09/2023 | 03/10/2023 | French | |
| Full model | 31/03/2022 | 12/09/2022 | 30/09/2022 | French | |
| Full model | 31/03/2021 | 13/09/2021 | 17/09/2021 | French | |
| Full model | 31/03/2020 | 14/09/2020 | 22/10/2020 | Dutch | |
| Full model | 31/03/2020 | 14/09/2020 | 22/10/2020 | French | |
| Full model | 31/03/2019 | 09/09/2019 | 11/09/2019 | Dutch | |
| Full model | 31/03/2019 | 09/09/2019 | 11/09/2019 | French | |
| Full model | 31/03/2018 | 10/09/2018 | 19/09/2018 | French | |
| Full model | 31/03/2018 | 10/09/2018 | 19/09/2018 | Dutch | |
| Full model | 31/03/2017 | 11/09/2017 | 04/10/2017 | French | |
| Full model | 31/03/2017 | 11/09/2017 | 04/10/2017 | Dutch | |
| Full model | 31/03/2016 | 12/09/2016 | 10/10/2016 | Dutch | |
| Full model | 31/03/2016 | 12/09/2016 | 13/09/2016 | French | |
| Full model | 31/03/2015 | 14/09/2015 | 28/09/2015 | Dutch | |
| Full model | 31/03/2015 | 14/09/2015 | 16/09/2015 | French | |
| Full model | 31/12/2013 | 09/06/2014 | 03/10/2014 | Dutch | |
| Full model | 31/12/2013 | 09/06/2014 | 16/06/2014 | French | |
| Full model | 31/12/2012 | 10/06/2013 | 25/07/2013 | Dutch | |
| Full model | 31/12/2012 | 10/06/2013 | 17/06/2013 | French | |
| Full model | 31/12/2011 | 11/06/2012 | 28/06/2012 | French | |
| Full model | 31/12/2011 | 11/06/2012 | 27/06/2012 | Dutch | |
| Full model | 31/12/2010 | 13/06/2011 | 14/07/2011 | Dutch | |
| Full model | 31/12/2010 | 13/06/2011 | 21/06/2011 | French | |
| Full model | 31/12/2009 | 14/06/2010 | 14/07/2010 | Dutch | |
| Full model | 31/12/2009 | 14/06/2010 | 21/06/2010 | French | |
| Full model | 31/12/2008 | 08/06/2009 | 11/06/2009 | French | |
| Full model | 31/12/2007 | 09/06/2008 | 01/07/2008 | French | |
| Full model | 31/12/2006 | 25/05/2007 | 20/06/2007 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 25 M€ and 50 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/01/20263 active · 20 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Restructuring16/09/2026OPERATION ASSIMILEE A UNE FUSION PAR ABSORPTION PAR LA ;
- Restructuring16/09/2026VERRICHTING GELIJKGESTELD MET FUSIE DOOR OVERNEMING DOOR
- Restructuring27/08/2026OPERATION ASSIMILEE A UNE FUSION PAR ABSORPTION DE LA |
- Restructuring27/08/2026VERRICHTING GELIJKGESTELD MET FUSIE DOOR OVERNEMING VAN DE !
- Restructuring10/07/2026CAPITAL, ACTIONS - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
- Restructuring10/07/2026KAPITAAL - AANDELEN - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates10/07/2026DEMISSIONS, NOMINATIONS
- Mandates10/07/2026ONTSLAGEN - BENOEMINGEN
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2026Annual accounts 20261,4 M €↓
- 01/01/2026augmentation_capital
- 01/12/2025augmentation_capital
- 18/06/2025nominationForvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BV — commissaris
- 18/06/2025nominationThomas Verhamme — vertegenwoordiger van de commissaris
- 18/06/2025nominationForvis Mazars Réviseurs d'Entreprises SRL/Bedrijfsrevisoren BV — commissaire
- 18/06/2025nominationThomas Verhamme — réviseur d'entreprises
- 01/06/2025augmentation_capital
- 2025Annual accounts 20251,7 M €↑
- 2025Name changeBENU
- 11/09/2023reconductionAn Marin — bestuurder
- 11/09/2023reconductionPhilippe Lacroix — bestuurder
- 11/09/2023reconductionArnaud Berken — bestuurder
- 11/09/2023nominationJulie Delforge — commissaris
- 11/09/2023reconductionAn Marin — administrateur
- 11/09/2023reconductionArnaud Berken — administrateur
- 11/09/2023reconductionPhilippe Lacroix — administrateur
- 11/09/2023nominationJulie Delforge — commissaire aux comptes
- 29/03/2022augmentation_capital
- 2021Annual accounts 20211,6 M €↑
- 2020Annual accounts 20201,2 M €↓
- 2019Annual accounts 20195,4 M €↑
- 2018Annual accounts 2018-1,4 M €↑
- 2017Annual accounts 2017-2,5 M €↑
- 2016Annual accounts 2016-5 M €↑
- 2012Annual accounts 2012-13,9 M €↓
- 2008Annual accounts 2008-8,3 M €↓
- 2006Annual accounts 2006-7,7 M €
- 2006Name changeLloydspharma Group
- 08/02/1989IncorporationPublic limited company